These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 7185528)
41. Audiotoxicity and nephrotoxicity due to orally administered neomycin. Greenberg LH; Momary H JAMA; 1965 Nov; 194(7):827-8. PubMed ID: 5898011 [No Abstract] [Full Text] [Related]
42. Letter: Neomycin toxicity. Little PJ; Lynn KL N Z Med J; 1975 May; 81(539):445. PubMed ID: 1057743 [No Abstract] [Full Text] [Related]
43. [Possibilities of ototoxic effects of orally administered neomycin in dyspepsia in infants. Experimental and audiometric study]. Zelenka J; Tomes D; Jilkova B Pediatrie; 1966; 21(5):573-83. PubMed ID: 5943516 [No Abstract] [Full Text] [Related]
44. [Nil nocere: Deafness caused by intramuscular neomycin therapy]. KORTGE-STOPPLER S; MITTAG G Munch Med Wochenschr; 1958 Aug; 100(32):1189-92. PubMed ID: 13577775 [No Abstract] [Full Text] [Related]
45. Profound deafness from neomycin sulfate. GOLDNER AI N Y State J Med; 1958 Jul; 58(13):2226-8. PubMed ID: 13566496 [No Abstract] [Full Text] [Related]
46. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa. Schwartz RH Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576 [TBL] [Abstract][Full Text] [Related]
55. Allergic contact dermatitis from gentamicin in eyedrops, with cross-reactivity to kanamycin but not neomycin. Sánchez-Pérez J; López MP; De Vega Haro JM; García-Díez A Contact Dermatitis; 2001 Jan; 44(1):54. PubMed ID: 11156029 [No Abstract] [Full Text] [Related]
56. Ototoxicity of metronidazole. Blake P; Butt WE N Z Med J; 1984 Apr; 97(753):241. PubMed ID: 6585722 [No Abstract] [Full Text] [Related]
57. Ototoxicity of metronidazole. Hibberd AD; Nicoll RJ; Macbeth WA N Z Med J; 1984 Apr; 97(754):275. PubMed ID: 6587218 [No Abstract] [Full Text] [Related]
58. [Topical neomycin: risks and benefits. Plea for withdrawal]. Assier-Bonnet H; Revuz J Ann Dermatol Venereol; 1997; 124(10):721-5. PubMed ID: 9740873 [No Abstract] [Full Text] [Related]
59. Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors. Doolittle ND; Muldoon LL; Brummett RE; Tyson RM; Lacy C; Bubalo JS; Kraemer DF; Heinrich MC; Henry JA; Neuwelt EA Clin Cancer Res; 2001 Mar; 7(3):493-500. PubMed ID: 11297239 [TBL] [Abstract][Full Text] [Related]
60. Interaction of neomycin, tobramycin and amikacin with melanin in vitro in relation to aminoglycosides-induced ototoxicity. Buszman E; Wrześniok D; Trzcionka J Pharmazie; 2007 Mar; 62(3):210-5. PubMed ID: 17416198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]